Results 51 to 60 of about 3,580,419 (303)

Breast cancer metastatic to the mandible

open access: yesJournal of Oral and Maxillofacial Surgery, 1982
Abstract One per cent of all malignant tumors produce metastatic foci in the jaws, with breast carcinoma being one of the most commonly metastasizing malignant tumors to the jaws in women. Such lesions should always be considered in the differential diagnosis of painful bone lesions, especially if there is a history of breast surgery for carcinoma.
Zachariades, N., Papanicolaou, S.
openaire   +3 more sources

Human WDR5 promotes breast cancer growth and metastasis via KMT2-independent translation regulation

open access: yeseLife, 2022
Metastatic breast cancer remains a major cause of cancer-related deaths in women, and there are few effective therapies against this advanced disease.
Wesley L Cai   +18 more
doaj   +1 more source

Cure in metastatic breast cancer [PDF]

open access: yesmemo - Magazine of European Medical Oncology, 2018
Oligometastatic disease characterizes a distinct subgroup of metastatic breast cancer patients that might benefit from different treatment strategies to achieve long-lasting remission and potentially cure. Those long-lasting remissions are reported after locoregional treatment of the primary tumor and all metastatic sites in several case series ...
Westphal, Theresa   +3 more
openaire   +2 more sources

Trastuzumab (Herceptin (R)): Monoclonal antibody in the treatment of HER2/neu-overexpressing breast cancer in the metastatic and (neo)adjuvant situation [PDF]

open access: yes, 2006
Trastuzumab (Herceptin (R)) is a humanized monoclonal antibody that specifically targets HER2/neu (human epidermal growth factor receptor-2) breast cancer cells, which are overexpressed in about 25-30% of breast carcinomas.
Bauerfeind, Ingo   +7 more
core   +1 more source

Safety of Daprodustat for the Treatment of Chronic Kidney Disease Anemia: Final Analysis of a Multicenter Postmarketing Surveillance Study in Japan

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction This final analysis of a multicenter, prospective postmarketing surveillance study evaluated the safety of daprodustat in patients with chronic kidney disease anemia in routine clinical practice in Japan. Methods Patients who initiated daprodustat between September 2020 and July 2022 were registered.
Tadao Akizawa   +7 more
wiley   +1 more source

Tumor markers in breast cancer - European Group on Tumor Markers recommendations [PDF]

open access: yes, 2005
Recommendations are presented for the routine clinical use of serum and tissue-based markers in the diagnosis and management of patients with breast cancer.
Einarsson, Roland   +10 more
core   +1 more source

Exercise as part of survivorship care in metastatic breast cancer: protocol for the randomized EMBody trial

open access: yesBMC Cancer
Background Exercise is associated with improved survival, physical functioning, treatment tolerability, and quality of life in early-stage breast cancer. These same endpoints matter in metastatic breast cancer (MBC).
Martha A. Cancilla   +12 more
doaj   +1 more source

Reducing stigma, isolation, and misconceptions in advanced breast cancer: a global expert review and call-to-action for 2025–2035 (Goal 8)

open access: yesBreast
Despite significant advances in the diagnosis and treatment of advanced breast cancer (ABC), people living with the disease continue to experience profound social isolation on a global scale. The multifaceted physical, financial, and emotional challenges
Ranjit Kaur   +8 more
doaj   +1 more source

Sequential Metastatic Breast Cancer Chemotherapy:Should the Median be the Message?

open access: yesFrontiers in Public Health, 2013
Background: Counseling and anticipatory guidance of the expected course of treatment for women newly diagnosed with metastatic breast cancer (MBC) are difficult due to multiple factors influencing survival following metastatic breast cancer therapy.
Su Yon eJung, Margaret eRosenzweig
doaj   +1 more source

Epigenetic reprogramming of lineage switching in cancer

open access: yesFEBS Letters, EarlyView.
Cancer cells rarely commit to a single identity. Epigenetic mechanisms and tumor microenvironment cues push epithelial cells toward flexible, hybrid states that can shift into mesenchymal, neuroendocrine, or stem‐like fates, driving metastasis, drug resistance, and tumor heterogeneity. Targeting the epigenetic regulators behind these transitions, using
Ezgi Boyvatlı   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy